101 related articles for article (PubMed ID: 11548510)
1. The real cost of development.
GMHC Treat Issues; 2001; 15(7-8):16. PubMed ID: 11548510
[No Abstract] [Full Text] [Related]
2. What does R&D really cost?
Huff B
GMHC Treat Issues; 2001; 15(7-8):1-7. PubMed ID: 11548507
[No Abstract] [Full Text] [Related]
3. The cost of developing new drugs.
Oncology (Williston Park); 1992 Jan; 6(1):142-3. PubMed ID: 1531601
[No Abstract] [Full Text] [Related]
4. Drugs firms inflate research costs, watchdog says.
Knight J
Nature; 2001 Aug; 412(6847):571. PubMed ID: 11493879
[No Abstract] [Full Text] [Related]
5. [Drug development in oncology. Its status and outlook with special consideration of the position of Germany].
Strohmeyer T; Weissbach L
Dtsch Med Wochenschr; 1999 Feb; 124(8):231-5. PubMed ID: 10093574
[No Abstract] [Full Text] [Related]
6. The cost of developing imaging agents for routine clinical use.
Nunn AD
Invest Radiol; 2006 Mar; 41(3):206-12. PubMed ID: 16481902
[TBL] [Abstract][Full Text] [Related]
7. The price of innovation: new estimates of drug development costs.
DiMasi JA; Hansen RW; Grabowski HG
J Health Econ; 2003 Mar; 22(2):151-85. PubMed ID: 12606142
[TBL] [Abstract][Full Text] [Related]
8. Cost reduction throughout the lifecycle.
Seeney P
Med Device Technol; 2007; 18(3):61-3. PubMed ID: 17585726
[TBL] [Abstract][Full Text] [Related]
9. Research and development costs for drugs.
Riggs TL
Lancet; 2004 Jan; 363(9404):184. PubMed ID: 14738789
[No Abstract] [Full Text] [Related]
10. Incremental drug treatment cost in HIV-positive patients in industry-sponsored clinical trials.
Perrín RS; López FJ
Ann Pharmacother; 2008 Nov; 42(11):1586-91. PubMed ID: 18780807
[TBL] [Abstract][Full Text] [Related]
11. [Drug development costs are overstated by the industry].
Jeppsson A
Lakartidningen; 2006 Mar 1-7; 103(9):663-4; discussion 664. PubMed ID: 16583545
[No Abstract] [Full Text] [Related]
12. The cost of therapy.
Somberg JC
Am J Ther; 2000 Nov; 7(6):343-4. PubMed ID: 11304640
[No Abstract] [Full Text] [Related]
13. [GlaxoSmithKline again lowers prices of drugs for HIV/AIDS and malaria].
Krankenpfl J; 2002; 40(7-9):222-3. PubMed ID: 12514863
[No Abstract] [Full Text] [Related]
14. New estimates of drug development costs.
Frank RG
J Health Econ; 2003 Mar; 22(2):325-30. PubMed ID: 12606149
[No Abstract] [Full Text] [Related]
15. Cost of new drugs.
Goozner M
Health Aff (Millwood); 2005; 24(3):883-4; author reply 884-5. PubMed ID: 15886185
[No Abstract] [Full Text] [Related]
16. Key factors in the rising cost of new drug discovery and development.
Dickson M; Gagnon JP
Nat Rev Drug Discov; 2004 May; 3(5):417-29. PubMed ID: 15136789
[No Abstract] [Full Text] [Related]
17. Opinion: development of new drugs is still a risky business.
Franks B
N J Med; 2002; 99(1-2):60, 59. PubMed ID: 15326736
[No Abstract] [Full Text] [Related]
18. [Cheap copies are a threat to research].
Mandahl H
Lakartidningen; 1990 Nov; 87(45):3728-9. PubMed ID: 2233049
[No Abstract] [Full Text] [Related]
19. Boulder blues.
Chou L
GMHC Treat Issues; 2003; 17(1-2):12-3. PubMed ID: 12691030
[No Abstract] [Full Text] [Related]
20. Cost/success projections for US biodefense countermeasure development.
Matheny J; Mair M; Smith B
Nat Biotechnol; 2008 Sep; 26(9):981-3. PubMed ID: 18779804
[No Abstract] [Full Text] [Related]
[Next] [New Search]
